Fig. S1. In vitro results at RF saturation field strength of 3 μΤ. Fig. S2 . In vitro pH measurement variation as a function of ΔΒ 0 shift at 4-μΤ RF saturation power. Fig. S3 . In vitro pH measurement variation with ΔΒ 0 shift at 3-μΤ RF saturation power. Fig. S10 . pH images calculated for a healthy control mouse using our 72, 38, and 2-offset protocols.
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